Should You Buy SpaceX Stock Right Now?

SpaceX is valued at over $2T despite only $4.69B in first-quarter sales, implying a price-to-sales ratio above 100, while it reported a $4.28B net loss in the quarter. The article questions the credibility of Musk’s $100B annual revenue target by 2028, arguing it requires more than a 20x jump in revenue with perfect execution and could weigh on the stock if losses persist. It cites large AI/data-center contract commitments (e.g., Alphabet at ~$920M/month and Anthropic near ~$45B over three years) as upside support, but emphasizes current fundamentals are being masked by speculation.

Analysis

The key market mechanism is not the revenue target itself, but the financing gap required to get there. When an asset is priced at an extreme sales multiple while still funding losses, equity holders are effectively underwriting multiple years of execution risk, capital raises, and dilution before any operating leverage shows up. That makes the stock vulnerable to a sharp de-rating if growth merely remains strong instead of accelerating to a near-perfect curve.

The more durable beneficiaries are upstream suppliers and adjacent infrastructure providers, not the equity story. If large AI/compute contracts are real, value accrues to GPU vendors, networking, power, and data-center enablement; the company carrying the balance-sheet risk captures the lowest-quality economics. For listed names, NVDA is the cleaner expression of incremental compute demand, while GOOGL benefits more as a customer buying optionality than as a direct earnings lever.

The contrarian risk is that investors are still treating Musk optionality as if it were an operating asset, when it is really a sentiment premium. That premium can persist for months, but it usually breaks only after a missed funding milestone, a weaker-than-expected booking cadence, or evidence that margins stay deeply negative despite topline growth. If the next disclosure shows revenue inflecting without proportional cash burn, the short thesis weakens; absent that, the stock can remain expensive but still lose multiples.

From a timing perspective, the immediate move is mostly sentiment-driven, but the 1-3 month catalyst is the next verification point on backlog conversion and financing terms. Over 6-18 months, the structural risk is that the market stops paying for narrative before profitability arrives, forcing a lower multiple even if the business keeps growing. That is where the asymmetry sits: limited upside if the story is merely good, but meaningful downside if growth is anything less than immaculate.

Key Decisions for Investors

• Short SPCX on strength or via 3-6 month put spreads; thesis is multiple compression from >100x sales toward a still-rich but more defensible range if cash burn persists. Falsify this on a clear step-down in quarterly losses or a materially better funding valuation.
• Use NVDA as the cleaner long for incremental compute spend rather than chasing SPCX exposure. Prefer a long NVDA / short SPCX relative-value stance if you want to express the difference between monetized demand and narrative premium.
• Treat GOOGL as a low-beta beneficiary only if the contract terms prove durable and margin-accretive; otherwise keep it as a watch item, not a momentum trade. The key catalyst is whether AI infrastructure spend becomes recurring and scalable within 1-2 quarters.
• Avoid adding to other high-multiple, cash-burning private/near-private growth exposures until SPCX proves it can narrow losses faster than revenue growth. If similar names fail to re-rate despite strong AI demand, that would confirm the market is repricing long-duration optionality.